Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000228

EVP, Chief Business Officer sold 250 shares at $62.00 ($15,500)

  • EVP, Chief Business Officer acquired 250 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Baroldi Joseph · EVP, Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-05 Exercise or conversion : show line 1 in the form 10b5-1 +250 $31.80 $7,950 32,176 D
2025-09-05 Sale : show line 2 in the form 10b5-1 −250 $62.00 $15,500 31,926 D
Open-market sales · 250 sh · avg $62.00 · $15,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-05 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −250 53,650 D
Loading xslF345X05/edgardoc.xml…